Skip to main content
Contact Us
Subscribe
E-Edition
70°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alpha Tau Medical Ltd. - Ordinary Shares
(NQ:
DRTS
)
2.300
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.300
Bid (Size)
2.100 (1)
Ask (Size)
2.300 (9)
Prev. Close
2.300
Today's Range
2.300 - 2.300
52wk Range
1.750 - 3.400
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
October 21, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Treats First Patient with Recurrent Lung Cancer
October 10, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Performance
YTD
-23.33%
-23.33%
1 Month
+0.88%
+0.88%
3 Month
+13.30%
+13.30%
6 Month
-6.50%
-6.50%
1 Year
-27.44%
-27.44%
More News
Read More
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
September 20, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Expert Ratings for Alpha Tau Medical
December 15, 2023
Via
Benzinga
Analyst Ratings for Alpha Tau Medical
November 17, 2023
Via
Benzinga
DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q2 2024
August 14, 2024
Via
InvestorPlace
Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers
June 25, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q1 2024
May 20, 2024
Via
InvestorPlace
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
May 13, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q4 2023
March 07, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 10, 2024
Via
Benzinga
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer
November 28, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer
November 20, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility
October 30, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 25, 2023
Via
Benzinga
Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board
October 24, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical Center
September 14, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
August 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 18, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
August 18, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
August 17, 2023
Via
Benzinga
Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT
August 17, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.